rs766521030
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_022166.4(XYLT1):c.154G>A(p.Gly52Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00135 in 1,111,762 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_022166.4 missense
Scores
Clinical Significance
Conservation
Publications
- Desbuquois dysplasia 2Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Desbuquois dysplasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- XYLT1-congenital disorder of glycosylationInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| XYLT1 | NM_022166.4 | c.154G>A | p.Gly52Ser | missense_variant | Exon 1 of 12 | ENST00000261381.7 | NP_071449.1 | |
| XYLT1 | XM_047434458.1 | c.154G>A | p.Gly52Ser | missense_variant | Exon 1 of 11 | XP_047290414.1 | ||
| XYLT1 | XM_017023539.3 | c.154G>A | p.Gly52Ser | missense_variant | Exon 1 of 12 | XP_016879028.1 | ||
| LOC107987234 | XR_001752091.2 | n.-216G>A | upstream_gene_variant |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| XYLT1 | ENST00000261381.7 | c.154G>A | p.Gly52Ser | missense_variant | Exon 1 of 12 | 1 | NM_022166.4 | ENSP00000261381.6 |
Frequencies
GnomAD3 genomes AF: 0.000913 AC: 134AN: 146762Hom.: 1 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.00119 AC: 49AN: 41118 AF XY: 0.00120 show subpopulations
GnomAD4 exome AF: 0.00142 AC: 1367AN: 964890Hom.: 6 Cov.: 29 AF XY: 0.00144 AC XY: 669AN XY: 466032 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000912 AC: 134AN: 146872Hom.: 1 Cov.: 30 AF XY: 0.000867 AC XY: 62AN XY: 71498 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; In silico analysis, which includes splice predictors and evolutionary conservation, suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge -
Desbuquois dysplasia 1 Benign:1
- -
XYLT1-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at